MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $52.17
0.46 (0.89%) Open Price: 52.17

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(12/20/24) $52.17
(12/21/24) $51.71
(12/21/24) (Qty.)190,982
(12/20/24) $50.21
(12/20/24) $54.10
(12/15/24) $50.21
(12/15/24) $58.26
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing